Bacteriuria in patients with spinal cord injury.
Arego
D E
DE
Koch
S J
SJ
D000617:Aminoglycosides / Q000627:therapeutic use; D001437:Bacteriuria / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D002408:Catheters, Indwelling / Q000009:adverse effects; D002511:Cephalosporins / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008709:Methenamine / Q000009:adverse effects / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D013119:Spinal Cord Injuries / Q000150:complications*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use; D013754:Tetracyclines / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D001743:Urinary Bladder / Q000033:anatomy & histology / Q000294:innervation / Q000382:microbiology*; D014546:Urinary Catheterization / Q000009:adverse effects
D000617:Aminoglycosides; D002511:Cephalosporins; D004338:Drug Combinations; D013754:Tetracyclines; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009582:Nitrofurantoin; D014295:Trimethoprim; D008709:Methenamine; D013420:Sulfamethoxazole